Navigation Links
Clinical Diagnostic Lab Testing Market to Grow Over 90% through 2017
Date:4/14/2009

Washington G-2 Reports releases 2009 Laboratory market projections.

NEWARK, N.J., April 14 /PRNewswire/ -- A new study from market research firm Washington G-2 Reports indicates that the clinical diagnostic lab testing market will reach $98.4 billion in revenue by 2017. An increase in genetic testing, esoteric testing, consumer driven healthcare, aging demographics and expanded access to healthcare are among the key factors contributing to strong market growth.

Washington G-2 Reports' Lab Industry Strategic Outlook: Market Trends & Analysis 2009 also shows other key factors contributing to the rapid evolution of the clinical diagnostic lab testing industry -- for instance, the M&A wave that hit the industry over the past two years --settling in 2009. That's not to say that M&A will become obsolete. Together, Quest, LabCorp and Sonic Healthcare snapped up 21 acquisitions in 24 months. The three companies remain preoccupied with dominating specific geographic markets and Washington G-2 Reports expects they will monopolize the industry for some time to come.

In addition to providing critical insight into the U.S. clinical laboratory testing market through 2017 and critical data on M&A, Washington G-2 Reports' Lab Industry Strategic Outlook provides expert perspective on, how contemporary trends will shape the structure the growth of the laboratory industry. This includes comprehensive analysis of four key providers (hospital, independent laboratory, physician offices, and 'other' services) four primary markets (Medicare, Medicaid, esoteric testing, anatomic pathology and cytology, and workplace drug testing) and penetration into new markets.

Lab Industry Strategic Outlook: Market Trends & Analysis 2009 is rich with laboratory rankings, including the: Top 75 Hospital Labs; Top 100 Independent Laboratory Corporations, Top 100 Physician Office Laboratories, Top Esoteric Testing Laboratories, Top Four Esoteric Laboratory Testing Providers, and more. In addition, the research provides profiles of 10 publicly traded U.S. laboratory and pathology companies: Bio-Reference Laboratories, Enzo Biochem, Genzyme Genetics, Laboratory Corporation of America, Medtox Scientific, Myriad Genetics, Psychemedics Corporation, Quest Diagnostics, Monogram Biosciences (Formerly ViroLogic, Inc.) and NeoGenomics. Each profile subsumes critical contact info (address, telephone, email, fax, names of leading employees (e.g., CEO, VPs, Directors)), a company overview, and financial information (e.g., revenue, pre-tax and net income, shareholder's equity, earnings per share, long-term debt, cash/equivalents, bad-debt %).

Lab Industry Strategic Outlook is an exclusive 294 page report supported by 160 tables and charts. For more details, call 973-718-4737, email pwpatterson@ioma.com or visit www.g2reports.com.

About Washington G-2 Reports

An independent news and information service, specializing in diagnostic testing and related medical services, Washington G-2 Reports is the leading market research and publishing firm serving the clinical diagnostic laboratory market in the U.S. Washington G-2 Reports offers timely, accurate reporting and analysis to subscribers in all 50 states, Puerto Rico, Canada, Europe and Asia; and is trusted by leading organizations such as the Centers for Disease Control and Prevention (CDC), which used Lab Industry Strategic Outlook (2007 edition) in their report, Laboratory Medicine: A National Status Report. In addition to publishing a variety of newsletters, reference guides and research, Washington G-2 Reports sponsors the Lab Institute and other related programs. Washington G-2 Reports is a division of the Institute of Management and Administration (IOMA, Newark, N.J.), a subsidiary of the Bureau of National affairs (Washington, D.C.).


'/>"/>
SOURCE Washington G-2 Reports
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. SNM clinical trials network expands phantom program for evaluating imaging centers
2. The American Federation for Medical Research Unites Top Leaders to Mitigate U.S. Crisis in Clinical Research
3. PlumSmart Plum Juice Clinically Proven to Help Regulate Digestion, Naturally
4. Dialysis Corporation of America Announces Establishment of Clinical Grant Agreement with the University of Cincinnati, College of Medicine
5. Cordex Pharma to Collaborate with BG Medicine in a Clinical Study of Heart Failure Biomarkers
6. Avineuro Pharmaceuticals, Inc. Announces Beginning of Phase I Clinical Studies of AVN-101, Potent Small Molecule for Treatment of Alzheimers Disease.
7. M2S Announces Agreement with AG Mednet to Provide Clinical Trial Sponsors with More Options for Efficient Image Transfer and Collection
8. Black Hills Orthopedics & Spine Center Selects Sage Intergy EHR to Improve Clinical, Operational and Financial Efficiencies
9. New head-to-head clinical studies reveal Reach Ultraclean toothbrush and floss deliver superior plaque removal compared to leading competitive products
10. Community Hospitals Remain Competitive with Latest Enhancement to Siemens MedSeries4 Clinical Suite
11. Siemens Announces Latest Contracts, Recent Go Lives, and Strong Customer Support for its Workflow-Enhancing Healthcare IT Solution Soarian Clinicals, at HIMSS 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... California (PRWEB) , ... June 27, 2016 , ... "FCPX ... fully customizable inside of Final Cut Pro X," said Christina Austin - CEO of ... unique style. Final Cut Pro X users can now reveal the media ...
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
Breaking Medicine Technology: